NTII Neurobiological Technologies (MM)

EMERYVILLE, Calif., May 4 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (NASDAQ:NTII) announced today it will release its third quarter fiscal 2007 financial results for the quarter ended March 31, 2007, on May 9, 2007 and will host a conference call on May 14, 2007. The conference call will be broadcast over the Internet. Hosting the call will be Paul E. Freiman, President and Chief Executive Officer, and Craig W. Carlson, Vice President and Chief Financial Officer. The details for the call are as follows: Live Call: -- Date: Monday, May 14, 2007 -- Time: 9:30 a.m. ET, 8:30 a.m. CT, 7:30 a.m. MT, 6:30 a.m. PT -- Dial-in number: 800-811-8845 (U.S.) 913-981-4905 (International) Webcast of Call: -- A live webcast can be accessed online by going to: http://www.shareholder.com/ntii/medialist.cfm The call will be archived and accessible at the same website for 90 days Telephonic Replay: -- Playback of the conference call will be available from 12:30 p.m. ET on May 14, 2007 through 11:59 p.m. (ET) on May 18, 2007. -- Replay number: 888-203-1112 (U.S. and Canada) & 719-457-0820 (International) -- Replay access code: 4287788 About Neurobiological Technologies, Inc. NTI is a biotechnology company engaged in the business of acquiring and developing central nervous system related drug candidates. The Company is focused on therapies for neurological conditions that occur in connection with ischemic stroke and brain cancer. The Company's strategy is to in-license and develop later-stage drug candidates that target major medical needs and that can be rapidly commercialized. NTI's experienced management team oversees the human clinical trials necessary to establish preliminary evidence of efficacy. DATASOURCE: Neurobiological Technologies, Inc. CONTACT: Craig W. Carlson, Vice President & CFO of Neurobiological Technologies, Inc., +1-510-595-6000 Web site: http://www.ntii.com/

Copyright